Cardiology News

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its analytical services portfolio with standalone analytical capabilities for biotechnology and pharmaceutical clients. The new approach provides access to Cytovance's experienced analytical team and regulatory-ready analytical solutions without requiring a manufacturing engagement. Building on...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--UNC Health Launches UNC Health Ventures...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa....

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued...

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced today that its shares have begun trading on the KOSDAQ market. The IPO marks a significant milestone as the company accelerates the development and global commercialization of its proprietary vascular stabilization pipeline. Founded in Boston in 2018, Ingenia is developing next-generation antibody therapeutics based on technologies ori...

GEORGETOWN, Texas--(BUSINESS WIRE)--Radiation Detection Company (RDC), the world's longest-operating providers of occupational dosimetry services, today announced the launch of Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures. Built specifically to reduce staff radiation exposure in environments such as cardiac catheterization laboratories, interventional...

CINCINNATI--(BUSINESS WIRE)--FDA approves an autoinjector for LEROCHOL® (lerodalcibep-liga), the only PCSK9 inhibitor patients self-administer once monthly in a single injection....

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced full enrollment of its TETON-PPF study evaluating the use of Tyvaso® (treprostinil) inhalation solution (nebulized Tyvaso) for the treatment of progressive pulmonary fibrosis (PPF). The TETON-PPF study enrolled 754 patients. “The rapid pace of enrollment underscores both the significant unmet need for new treatment options in PPF and the strong interest in nebulized Tyvas...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2026 Results...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the second quarter ended June 30, 2026, and provided a business update. “We have worked hard to strengthen Gossamer and...